Ergoteles LLC - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 132 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$169,175
-37.2%
50,500
-9.9%
0.01%
-30.0%
Q4 2022$269,509
-91.3%
56,031
+11.3%
0.01%
-89.7%
Q1 2021$3,110,00050,3620.10%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,637,331$57,405,00037.04%
Bain Capital Life Sciences Investors, LLC 3,700,000$129,722,0008.05%
Cormorant Asset Management, LP 4,928,756$172,802,0007.02%
RA Capital Management 5,427,655$190,294,0002.64%
CM Management, LLC 100,000$3,506,0002.62%
Ghost Tree Capital, LLC 150,000$5,259,0001.54%
ORACLE INVESTMENT MANAGEMENT INC 309,126$10,838,0001.35%
Perceptive Advisors 2,259,224$79,208,0001.15%
Omega Fund Management, LLC 164,577$5,770,0000.65%
Monashee Investment Management LLC 100,000$3,506,0000.65%
View complete list of ATEA PHARMACEUTICALS INC shareholders